The Measles and Rubella Partnership has spent much effort fighting for its cause by means of widespread education. One of the main mediums used is Power Point presentations. Below you will find some of the Partnership’s archived presentations.
Quick links to the previous reports on this page
- 2024 Measles and Rubella Partnership Partners Meeting
- 2019 Measles and Rubella Partnership Partners Meeting
- 2018 A Dialogue with Pediatric Societies and Immunization Partners Meeting
- 2017 Global Measles and Rubella Partnership Partner Meeting
- 2016 Acceleration Towards Measles and Rubella Elimination
- 2015 Global Measles and Rubella Annual Meeting
- 2015 Africa Technical Advisory Group (TAG) Meeting
- 2014 Global Measles and Rubella Annual Meeting
- 2013 Global Measles and Rubella Annual Meeting
- 2012 Global Measles and Rubella Annual Meeting
- 2011 Global Measles Management Meeting
- 2011 Global Measles and Rubella Annual Meeting
- Other
2024 Measles and Rubella Partnership Partners Meeting
Agenda
List of Participants
Meeting Summary
Advocacy in Action – Shot@Life’s formula for Global Immunization Support
Egypt- Path to achieving Rubella and CRS elimination
Gavi-UNICEF joint session – Using Immunisation to strengthen PHC
Global Measles and Rubella Lab Network Perspective
Global Polio Eradication Perspective – Overview of Polio Integration
Measles & Rubella Strategic Framework – Revising Monitoring & Evaluation Framework
Measles and Rubella surveillance Experience from the Tanzania National Public Health Laboratory
Micro-Array Patch Introduction
Not Business as Usual- Why Measles & Rubella are Important Now
Operationalize Measles as a Tracer
Opportunities to use communication to drive collective action toward M&RP priorities
Social Mobilization & How Communities Make Impact
Story from Field – 5-Point Plan
Story from the Field- An Innovation to Address Inequalities – Microarray Patches
Successful Communications Strategies to Reach Zero Dose Children in India
Using Immunization to Strengthen Primary Health Care
Celebrating the 50th Anniversary of the Expanded Program on Immunization
HOA Video – UNICEF – Catherine Russel
American Red Cross Gail McGovern
Bill & Melinda Gates Foundation, Chris Elias
Gavi, the Vaccine Alliance, Aurelia Ngyuen
2019 Measles and Rubella Partnership Partners Meeting
Agenda
List of Participants
September 11-12, 2019 – Day One
Dr Hinman Lifetime Achievement Acceptance Speech
Ms. Henrietta Fore, Executive Director, UNICEF (video)
WHO Global overview of progress and challenges
PAHO- Response in the Americas to measles importations
Colombia Outbreak response in a setting of humanitarian need (2)
Philippines Red Cross Responding to the 2019 Measles Outbreak in the Philippines
Vaccinations Science Controversy and Public Trust The Story of Clark County 2019 Measle Outbreak
Outbreaks Summary of lessons learnt and the vision for the future final
Viewpoint from the CDC Director Dr. Robert Redfield
A rapid diagnostic test for measles Can it transform surveillance
Creating the MR post 2020 framework
Laying the Foundation for a Successful Future
September 11-12, 2019 – Day Two
Communications Panel – Measles Moves Fast, Our External Communications Should Too
Family Perspective – My Familys Story Living with Congenital Rubella Syndrome
Moving the Needle on Capitol Hill Grassroots Advocacy
Measles and Rubella Vaccinations by Microneedle Patch
American Red Cross 5 Point Plan
2018 A Dialogue with Pediatric Societies and Immunization Partners Meeting
Agenda
List of Participants
May 23, 2018
American Academy of Pediatrics Global Immunization Champions project
Best Practice Guidance Respond Vocal Vaccine Deniers
CDC Measles-Rubella Elimination Team
Civil society support in MR elimination to date
Global Status of Measles and Rubella Elimination Activities
Introduction to the Gavi CSO Platforms Project
Role of Indonesia Pediatric Society in Immunization
Role of Kenya Paediatric Association in Immunizations
Role of Paediatric Association of Nigeria in Immunizations
Role of Philippine Pediatric Society in Immunizations
What we know about vaccine hesitancy and the role of pediatric societies
MRI Pediatric Societies Summary and Next Steps
2017 Global Measles and Rubella Partnership Partner Meeting
Agenda
List of Participants
September 7-8, 2017 – Day One
Conducting a Mass Measles Campaign Among Internally Displaced Populations in Northeast Nigeria
India MR Communication Strategy
Keynote Address – Dr. Alan Hinman
Measles and Rubella Vaccination Using a Microneedle Patch
Measles Containing Vaccines, Overview of Supply Through UNICEF
Risks and Opportunities of Transitioning Polio Resources to Support MR Elimination
Surveillance and Why it is Important
September 7-8, 2017 – Day Two
Characterizing the Health and Financial Costs of Measles and Rubella
Opportunities in the Second Year of Life
Philippines-Strengthening Routine Immunization in Urban Poor Communities
Red Cross Volunteers Experience
Story From the Field – Malawi GIS
The Role of Pediatricians and National Pediatric Societies
Acceleration Towards Measles and Rubella Elimination 2016
June 21-24, 2016 – Day One
Global Measles and Rubella Update
Global Measles Rubella Laboratory Network (GMRLN) update
Findings and Recommendations from the Midterm Review
The Experience with the M&RP Outbreak Response Fund Lessons Learned
Midterm Review Recommendations on Outbreak Response
Updates from the Regional MR Laboratory Networks WPR
Updates from the Regional MR Laboratory Networks SEAR
Updates from the Regional MR Laboratory Networks EMR
Updates from the Regional MR Laboratory Networks EUR
European Regional Presentation
Southeast Asia Regional Presentation
Western Pacific Regional Presentation
Eastern Mediterranean Regional Presentation
Americas Regional Presentation
June 21-24, 2016 – Day Two
Cross Cutting MR and RI Priorities
Overview of Second Year of Life
India Experience with Measles 2nd Dose and DPT Booster in 2nd Year of Life
Strengthening the 2YL Platform and Men A Introduction Plan in Ghana
Recording and Monitoring in the Second Year of Life
Dose Per Container Partnership
Lessons Learned and Key Factors Affecting SIA Quality
Micro-Planning to Ensure SIA Reaches the Unvaccinated
SIA Readiness Assessment Tool Uganda Experience
Post SIA Coverage Survey New WHO Vaccination Coverage Cluster Survey Reference Manual
Updates from the Regional MR Laboratory Networks AFR
Updates from the Regional MR Laboratory Networks AMR
Measles and Rubella IgM Proficiency Testing
Molecular EQA for GMRLN Year Two
Process and Results of First Molecular PT Exercise in EUR
Introduction and Comments on Measles Genotype Distribution and Lesson Learned
Overview of Measles and Rubella Genotypes and MeaNS and RubeNS Update
Multiple Genotypes Circulating in Russian Federation
Measles Genotype Diversity in SEAR
Whole Genome Sequencing for Measles a Case Study in Brazil
Evolution of Rubella Viruses During Persistent Infection
Evolution of Rubella Viruses Following Long Term Endemic Circulation
Progress on the Development of the Revised Laboratory Manual
N.E.W. Next Generation, Extended Window and Whole Genome Sequencing Working Group
Vaccine Specific RT PCR for Measles MeVA
Multiplex Bead Assay Multiplex Immuno Assay
National Institute of Infectious Diseases Update
Global Health Security Activities
June 21-24, 2016 – Day 3
Measles and Rubella Surveillance Roadmap
DRC Challenges with Multiple Surveillance Systems
How the Philippines Overcame the Surveillance Challenges Elicited by the 2014 Measles Outbreak
Measles and Rubella Surveillance in the time of Zika
Measles and Rubella Serosurveys
Innovations Measles Programmatic Risk Assessments
Disappearance of Measles Genotypes
Next Generation and Extended Sequencing Working Group for Measles and Rubella
Developing Point of Care Tests for Measles Surveillance
Mircroneedle Patches An Emerging Vaccine Delivery Technology to Achieve High
Coverage for Measles and Rubella Vaccines
Global Measles and Rubella Annual Meeting 2015
List of Participants
September 15-16, 2015 – Day One
From the Field: Ms. Sylvia Khamati, Kenya Red Cross Society
Achieving Success in Rubella Elimination: Dr. Jon Andrus, Sabin Vaccine Institute
Story From the Field: Dr. Jennifer Zipprich, California Department of Public Health
Stakeholder Consultation on the Mid-Term Review and the Way Forward
M&RP Financial Resource Requirements: Dr. Yodit Sahlemariam, UNICEF
Workshop on Communicating for Impact
September 15-16, 2015 – Day Two
Updates from Gavi, The Vaccine Alliance, Stefano Malvoti, Gavi
Polio Eradication: Transitioning the Infrastructure to Support Routine Immunization as Well as Measles and Rubella:
- Status of Global Poliomyelitis Eradication Initiative Legacy Planning and Implementation, Dr. Steve Cochi, CDC
- Country Viewpoint, Dr. Jeff McFarland, WHO on behalf of Ministry of Health India
- Country Viewpoint, Dr. Nada Ahmed, Ministry of Health Sudan
Economics of Measles and Rubella: Dr. Kim Thompson, Kid Risk
How Individuals Can Make a Difference in Eliminating Measles and Rubella:
Story from the Field: Ms. Julie Boonprasarn, Lions Clubs International Foundation
Story from the Field: Mr. Francis Kateh, Deputy Health Minister & Chief Medical Officer, Liberia
Africa Technical Advisory Group (TAG) Meeting 2015
June 2-3, 2015- Day One
Implementation of MR TAG Meeting 2013 Recommendations
Global Measles and Rubella Update
Regional Measles Elimination Program Updates
Invalid MCV1 Doses – How Big A Problem?
MCV2 Introduction and the Second Year of Life Contact
MR Introduction and Rubella Epidemiology in AFRO
Measles Vaccination in MSF Context
June 2-3, 2015- Day Two
Measles/ MR Supplemental Immunisation Activities Quality
Update on Measles & Rubella Surveillance in the WHO African Region
The Performance of the Regional Laboratory Network
Polio Legacy Planning Discussion
Global Measles and Rubella Annual Meeting 2014
List of Participants
September 9-10, 2014- Day One
M&RP Fundraising and Outreach Session
Outbreak Response Fund Presentation
September 9-10, 2014- Day Two
Routine Immunization Strengthening in Tanzania and Uganda
Global Measles and Rubella Annual Meeting 2013
List of Participants
September 10-11, 2013- Day One
The Golden Anniversary of Measles Vaccine
Progress in Creating a World Free of Measles & Rubella
Young People Helping Young People
EMRO: Focus on Response to Humanitarian Disaster
AFRO: Focus on Response to Measles Resurgence
EURO: Focus on Advocacy and Communication Response to Measles and Rubella Resurgence
September 10-11, 2013- Day Two
Social Mobilization in Practice
Tools for Strengthening SIAs and Routine Immunization
Engaging Government and Civil Society to Achieve the Elimination
WPRO: Final Push to Eliminate Measles and Control Rubella
SEARO: Focus on Plans to Eliminate Measles
Global Measles and Rubella Annual Meeting 2012
List of Participants
September 18-19, 2012 – Day One
Global Overview of Measles & Rubella
The Measles & Rubella Partnership: Preparing for the Next Decade
Priorities in the Measles and Rubella Research Agenda
Supporting the Measles Rubella Initiative Globally, Impacting Communities Locally
GAVI Support for Measles and Rubella Immunization
Funding Update: Current Situation and Future Prospects
Eliminating Measles: Western Pacific Region in Action
Progress towards Measles Elimination China, 2012
Progress on SIAs and MCV2 introduction in India
Measles mortality reduction in SEAR
Using Measles SIAs to Strengthen Routine Immunization
India Routine Immunization & Measles SIA synergies assessment
September 18-19, 2012 – Day Two
African Region – priorities to reach the 2020 measles elimination goal
Measles and rubella outbreaks in WHO Region of Europe
Measles Vaccination in Emergency Setting
Validation of measles & rubella elimination, challenges in Ecuador and Haiti
Monitoring the impact of vaccination on rubella and CRS
House to House Mobilization for successful measles SIAs: SITREP after five years in Africa
Measles and Rubella investment cases: Stakeholder analysis and update
Hong Kong Training Workshop, 2010
Measles & Rubella Partnership Advocacy & Communication
TRCS Experience on Social Mobilization for Integrated Measles Campaign of 2011
URCS Mass Measles Social Mobilization Campaign
Global Measles Management Meeting 2011
March 2011 – Day One
Decade of Vaccines – How can measles deliver?
Global measles and rubella technical update
What happened at the Strungmann Forum?
Proceedings of the SAGE Working Group on Rubella
Recommendations from the 2010 Global LabNet Meeting
Innovation and new technologies for measles eradication
Measles vaccination: Alternative delivery methods
Highlights and priorities – EURO
Highlights and priorities – WPRO
Progress toward measles elimination in China
Highlights and priorities – EMRO
Highlights and priorities – SEARO
Update on the Implementation of Measles Second Dose in India
Progress and challenges in Bangladesh
Highlights and priorities – AFRO
Measles outbreak in Malawi – Reasons and response
Experience in Ethiopia in conducting best practices measles campaign
Do we need a measles vaccine stockpile for more effective measles outbreak response?
Outline of the Measles Strategic Plan 2011-2020
Monitoring progress toward the coverage and disease incidence targets
New model for estimating progress towards the 2015 mortality reduction goal
Update on the global supply of measles and measles-rubella vaccine
Advocacy across the Measles Initiative
Global Measles and Rubella Annual Meeting 2011
Agenda
Eastern Mediterranean Region Update
East and Southern Africa Outbreaks
Measles Outbreak & Response 2009-2011: South Africa
Challenges in Measles Outbreak Response: MSF Perspectives
Rubella & Routine Immunization
Updated 2011 WHO Rubella Vaccine Position Paper and Implications for Regions and Countries
Achieving and Sustaining Measles and Rubella Elimination
Rubella Epidemiology in Africa
Routine Immunization: The Fifth Child Perspective
Global Measles and Rubella Strategic Plan
Measles Initiative Management and Financing
Economic Analysis of Measles Mortality Reduction and Eradication
Implementing a Best Practice: Ethiopia’s Experience
Measles Elimination in Pakistan
Update on Measles Mortality Reduction in India
American Red Cross Domestic Outreach
LDS Church and Red Cross Social Mobilization
Other
Partnership Alliance
The mark 'CDC' is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or enterprise. CDC's logo and work with the Partnership is not connected to any fundraising aspect of the organization.
Follow Us
Prelude Version 2.3.2